Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK112 with CapeOX and Radiotherapy in Metastatic MSS Colorectal Cancer
NCT06593548Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Nov 2024
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
A Phase 2 trial of ivonescimab in colorectal cancer (CRC), sponsored by Fudan University. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
ivonescimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06593548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06593548.